Park Avenue Securities LLC Acquires Shares of 6,509 iShares Biotechnology ETF $IBB

Park Avenue Securities LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, Holdings Channel.com reports. The fund bought 6,509 shares of the financial services provider’s stock, valued at approximately $1,099,000.

Other large investors have also modified their holdings of the company. Anderson Hoagland & Co. acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $2,977,000. Tudor Investment Corp ET AL acquired a new position in iShares Biotechnology ETF during the third quarter worth $931,000. CIBC Bancorp USA Inc. purchased a new position in iShares Biotechnology ETF in the third quarter worth $3,210,000. Captrust Financial Advisors raised its position in iShares Biotechnology ETF by 1.8% in the third quarter. Captrust Financial Advisors now owns 19,029 shares of the financial services provider’s stock worth $2,747,000 after acquiring an additional 334 shares in the last quarter. Finally, Advisory Services Network LLC lifted its holdings in iShares Biotechnology ETF by 22.6% in the third quarter. Advisory Services Network LLC now owns 4,876 shares of the financial services provider’s stock valued at $704,000 after acquiring an additional 900 shares during the period. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $165.75 on Thursday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64. The company’s fifty day moving average is $171.46 and its two-hundred day moving average is $163.93.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.